Skip to Content

Healthy Living for All

Colleagues across our Schools and Faculties are dedicated to deepening our understanding of diseases, and developing solutions and treatments for them.

Our expertise in conducting clinical trials and our world leading facilities in cancer and precision medicine research are a testament to the breakthroughs that Queen’s research has facilitated over the decades. We are also leading the way in developing strategies and initiatives which mitigate against the worst effects of illness and which act as preventative agents to illnesses developing in the first place.

A strong public health approach, focusing on community well-being, aligned with a commitment to social justice drives our pledge to improve health outcomes which can reduce inequalities across society.


Impact Case Studies

Ophthalmology clinical trial hailed as one of the most important of the Decade

Healthy Living for All

Ophthalmology research at Queen's University Belfast has a long-standing international reputation which has been built around high-quality basic science, patient studies and clinical trials. Queen’s researchers have developed internationally-recognised expertise in the genetics and treatment of age-related macular degeneration (AMD).

Their clinical trial known as IVAN (Inhibition of VEGF in Age-related choroidal Neovascularisation) has led to a rapid impact on policy, practice, and debate around the globe.

Reassembled, Slightly Askew - A Unique Immersive Theatrical Experience

Healthy Living for All, Inclusive and Cohesive Communities, Secure Connected Intelligence – AI and the Data Revolution

Reassembled, Slightly Askew (RSA) is an immersive audio-based artwork that transports you inside the head of artist Shannon Yee as she descends into coma from a rare brain infection and her re-emergence into the world with an acquired brain injury.

The work was created by a multidisciplinary team including Queen’s University’s Professor Paul Stapleton as composer/ Sound designer.

The Food Fortress- From a crisis to the formation of an innovative food quality assurance scheme

Healthy Living for All, Human-Environment Relations

The Food Fortress scheme developed by researchers at Queen’s University is recognised internationally as a World-leading risk management and feed quality assurance scheme.

Transforming supportive cancer care for patients and families

Healthy Living for All

Researchers from Queen’s have transformed supportive care for cancer survivors and their families through the development of a new model for follow up care termed ‘The Recovery Package’.

Transforming the lives of people with Cystic Fibrosis

Healthy Living for All

Researchers from Queen’s University Belfast have transformed the lives of thousands of people with Cystic Fibrosis by leading on the clinical development of treatments that address the underlying genetic disorder.

Uncovering the causes of a Major Crisis in the World Food Programme

Healthy Living for All, Human-Environment Relations, Inclusive and Cohesive Communities

For over 20 years, researchers at Queen’s have investigated the chemical contamination of foodstuffs for the benefit and safety of consumers around the world. In 2019 the team were called upon to identify the cause of a major contamination crisis in the UN World Food Programme (WFP).


Research Topics
  • Tackling cancer, infection, respiratory and eye diseases
  • Improving life course health and community well-being
  • Precision medicine and digital innovation to enhance healthcare solutions
  • Interventions and services to improve health and reduce inequality

Driving Innovation in Clinical Health Care Through the Belfast Region City Deal

Queen’s is leading the Institute for Research Excellence in Advanced Clinical Healthcare (iREACH), an integrated clinical research centre of excellence, and an NHS, industry, and research facility. It will transform the region’s ability to test new drugs, medical-technology, care pathways and societal interventions. It will leverage the opportunities that exist at the interface of medical research and digital transformation, resulting in better care for patients in a post-Covid world.